Clinical trials recruiting for Dyslipidemia Associated With Type II Diabetes Mellitus
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| BERLIM 25/20 ASSOCIATION | 1 |
| Empagliflozin | 1 |
| Ezetimibe or ezetimibe-statin combination therapy | 1 |
| Moderate-intensity statin monotherapy | 1 |
| ROSUVASTATIN CALCIUM | 1 |
Self-screener
Recruiting trials
- Dietary Strategies for Remission of Type 2 Diabetes
- Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.
- Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)
Related conditions
Trials recruiting for Dyslipidemia Associated With Type II Diabetes Mellitus often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Dyslipidemia Associated With Type II Diabetes Mellitus trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.